Download PDF
Semin Reprod Med 2003; 21(1): 027-038
DOI: 10.1055/s-2003-39992
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Evaluating the Medical Literature in Reproductive Medicine: Questions Concerning Prognosis

Jeremy M. Groll, Marc A. Fritz
  • Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Fertility, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Further Information

Publication History

Publication Date:
12 June 2003 (online)

    Permissions and Reprints

ABSTRACT

To illustrate the recommended approach to questions concerning prognosis and the formulation of clinical recommendations, the principles of evidence-based medicine were applied to questions regarding the cardiovascular health risks associated with polycystic ovary syndrome (PCOS) and the effects of treatment on risk. A critical examination of the published literature reveals that the clinical diagnosis of PCOS does not, by itself, increase the risk of developing coronary heart disease (CHD) or adversely affect the prognosis in women with CHD. Rather, any increased risks can be attributed to other known risk factors (obesity, hypertension, diabetes, dyslipidemia) commonly observed in women with the disorder. Treatment strategies that decrease the probability of developing such co-morbid conditions (diet, exercise) or are effective in their management (antihypertensives, statins, insulin-sinsitizing agents) may be expected to reduce risk or improve prognosis, but available evidence is insufficient to warrant a general recommendation for metformin treatment as a CHD risk reduction strategy in all women with PCOS.

KEYWORDS

Evidence-based medicine - polycystic ovary syndrome - coronary heart disease - metformin

REFERENCES

  • 1 Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine.  JAMA . 1992;  268 2420-2425
    Search in Google Scholar
  • 2 Guyatt G H, Haynes R B, Jaeschke R Z, Cook D J, Green L, Naylor C D. Users' guide to the medical literature XXV: evidence-based medicine-principles for applying the users' guides to patient care.  JAMA . 2000;  284 1290-1296
    CrossrefPubMedSearch in Google Scholar
  • 3 Oxman A D, Cook D J, Guyatt G H. Users' guide to the medical literature VI: how to use an overview.  JAMA . 1994;  272 1367-1371
    PubMedSearch in Google Scholar
  • 4 Mulrow C D. The medical review article: state of the science.  Ann Intern Med . 1987;  106 485-488
    PubMedSearch in Google Scholar
  • 5 McAlister F A, Clark H D, van Walraven C. et al . The medical review article revisited: has the science improved?.  Ann Intern Med . 1999;  131 947-951
    PubMedSearch in Google Scholar
  • 6 Canadian Task Force on the Periodic Health Examination. The periodic health examination.  Can Med Assoc J . 1979;  1193-1254
    PubMedSearch in Google Scholar
  • 7 US Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions Baltimore: Williams & Wilkins 1989
  • 8 Guyatt G H, Sackett D L, Sinclair J C, Hayward R, Cook D J, Cook R J. Users' guide to the medical literature IX: a method for grading health care recommendations.  JAMA . 1995;  274 1800-1804
    CrossrefPubMedSearch in Google Scholar
  • 9 Moher D, Schulz D K, Altman D. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.  JAMA . 2001;  285 1987-1991
    CrossrefPubMedSearch in Google Scholar
  • 10 Laupacis A, Wells G, Richardson W S, Tugwell P. Users' guide to the medical literature V: how to use an article about prognosis.  JAMA . 1994;  272 234-237
    CrossrefPubMedSearch in Google Scholar
  • 11 Talbott E O, Zborowski J V, Sutton-Tyrrell K, McHugh-Pemu K, Guzick D S. Cardiovascular risk in women with polycystic ovary syndrome.  Obstet Gynecol Clin North Am . 2001;  28 111-133
    CrossrefPubMedSearch in Google Scholar
  • 12 Rajkhowa M, Glass M R, Rutherford A J, Michelmore K, Balen A H. Polycystic ovary syndrome: a risk factor for cardiovascular disease?.  Br J Obstet Gynaecol . 2000;  107 111-118
    PubMedSearch in Google Scholar
  • 13 McKeigue P. Are women with polycystic ovary syndrome at special risk for coronary heart disease?.  Clin Endocrinol (Oxf) . 1992;  37 117-118
    PubMedSearch in Google Scholar
  • 14 Kelly C J, Connell J M, Cameron I T, Gould G W, Lyall H. The long term health consequences of polycystic ovary syndrome.  Br J Obstet Gynaecol . 2000;  107 1327-1338
    PubMedSearch in Google Scholar
  • 15 Solomon C G. The epidemiology of polycystic ovary syndrome.  Endocrinol Metab Clin North Am . 1999;  28 247-263
    CrossrefPubMedSearch in Google Scholar
  • 16 Amowitz L L, Sobel B E. Cardiovascular consequences of polycystic ovary syndrome.  Endocrinol Metab Clin North Am . 1999;  28 439-458
    CrossrefPubMedSearch in Google Scholar
  • 17 Legro R S, Kunselman A R, Dodson W C, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.  J Clin Endocrinol Metab . 1999;  84 165-169
    CrossrefPubMedSearch in Google Scholar
  • 18 Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J, Skibova J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.  Hum Reprod . 2000;  15 785-789
    CrossrefPubMedSearch in Google Scholar
  • 19 Elting M W, Korsen T JM, Bezemer P D, Schoemaker J. Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population.  Human Reprod . 2001;  16 556-560
    CrossrefPubMedSearch in Google Scholar
  • 20 Game F, Jones A F. Coronary heart disease risk assessment in diabetes mellitus: a comparison of PROCAM and Framingham risk assessment functions.  Diabet Med . 2001;  18 355-359
    CrossrefPubMedSearch in Google Scholar
  • 21 Miettinen H, Lehto S, Salomaa V. et al . Impact of diabetes on mortality after the first myocardial infarction.  <~~>The FINMONICA myocardial infarction register study group. Diabetes Care . 1998;  21 69-75
    PubMedSearch in Google Scholar
  • 22 Van Belle E, Bauters C, Hubert E. et al . Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.  Circulation . 1997;  96 1454-1460
    PubMedSearch in Google Scholar
  • 23 Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.  Endocr Rev . 1997;  18 774-800
    CrossrefPubMedSearch in Google Scholar
  • 24 Dahlgren E, Janson P O, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women.  Acta Obstet Gynecol Scand . 1992;  71 599-604
    CrossrefPubMedSearch in Google Scholar
  • 25 Dahlgren E, Johansson S, Lindstedt G. et al . Women with polycystic ovary syndrome wedge resected in 1956 to 1965; a long-term follow-up focusing on natural history and circulating hormones.  Fertil Steril . 1992;  57 505-513
    PubMedSearch in Google Scholar
  • 26 Birdsall M A, Farquhar C M, White H D. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization.  Ann Intern Med . 1997;  126 32-35
    CrossrefPubMedSearch in Google Scholar
  • 27 Vlietstra R E, Kronmal R A, Frye R L, Seth A K, Tristani F E, Killip III T. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study.  Arteriosclerosis . 1982;  2 208-215
    PubMedSearch in Google Scholar
  • 28 Pierpoint T, McKeigue P M, Isaacs A J, Wild S H, Jacobs H S. Mortality of women with polycystic ovary syndrome at long-term follow-up.  J Clin Epidemiol . 1998;  51 581-586
    CrossrefPubMedSearch in Google Scholar
  • 29 Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.  Clin Endocrinol . 2000;  52 595-600
    Search in Google Scholar
  • 30 Bucher H C, Guyatt G H, Cook D J, Holbrook A, McAlister F A. Users' guides to the medical literature XIX: applying clinical trial results: how to use an article measuring the effect of an intervention on surrogate end points.  JAMA . 1999;  282 771-778
    CrossrefPubMedSearch in Google Scholar
  • 31 NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. NIH consensus conference: triglyceride, high-density lipoprotein, and coronary heart disease.  JAMA . 1993;  269 505-510
    CrossrefPubMedSearch in Google Scholar
  • 32 Jeppesen J, Hein H O, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study.  Circulation . 1998;  97 1029-1036
    PubMedSearch in Google Scholar
  • 33 Vita J A, Treasure C B, Nabel E G. et al . Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.  Circulation . 1990;  81 491-497
    CrossrefPubMedSearch in Google Scholar
  • 34 Paradisi G, Steinberg H O, Hempfling A. et al . Polycystic ovary syndrome is associated with endothelial dysfunction.  Circulation . 2001;  103 1410-1415
    CrossrefPubMedSearch in Google Scholar
  • 35 Mather K J, Kwan F, Corenblum B. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.  J Clin Endocrinol Metab . 2000;  85 1851-1856
    CrossrefPubMedSearch in Google Scholar
  • 36 Teragawa H, Kato M, Kurokawa J, Yamagata T, Matsuura H, Chayama K. Usefulness of flow-mediated dilation of the brachial artery and/or the intima-media thickness of the carotid artery in predicting coronary narrowing in patients suspected of having coronary artery disease.  Am J Cardiol . 2001;  88 1147-1151
    CrossrefPubMedSearch in Google Scholar
  • 37 Mielke Jr H C, Shields J P, Broemeling L D. Risk factors and coronary artery disease for asymptomatic women using electron beam computed tomography.  J Cardiovasc Risk . 2001;  8 81-86
    CrossrefPubMedSearch in Google Scholar
  • 38 Keelan P C, Bielak L F, Ashai K. et al . Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography.  Circulation . 2001;  104 412-417
    CrossrefPubMedSearch in Google Scholar
  • 39 Talbott E, Clerici A, Berga S L. et al . Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.  J Clin Epidemiol . 1998;  51 415-422
    CrossrefPubMedSearch in Google Scholar
  • 40 Slowinska-Srzednicka J, Zgliczynski S, Wierzbicki M. et al . The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.  J Endocrinol Invest . 1991;  14 596-575
    PubMedSearch in Google Scholar
  • 41 Schachinger V, Britten M B, Zeiher A M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.  Circulation . 2000;  101 1899-1906
    CrossrefPubMedSearch in Google Scholar
  • 42 Chan N N, Colhoun H M, Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population.  J Am Coll Cardiol . 2001;  38 1814-1820
    CrossrefPubMedSearch in Google Scholar
  • 43 Talbott E O, Guzick D S, Sutton-Tyrrell K. et al . Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.  Arterioscler Thromb Vasc Biol . 2000;  20 2414-2421
    PubMedSearch in Google Scholar
  • 44 Mielke Jr H C, Shields J P, Broemeling L D. Risk factors and coronary artery disease for asymptomatic women using electron beam computed tomography.  J Cardiovasc Risk . 2001;  8 81-86
    CrossrefPubMedSearch in Google Scholar
  • 45 Keelan P C, Bielak L F, Ashai K. et al . Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography.  Circulation . 2001;  104 412-417
    CrossrefPubMedSearch in Google Scholar
  • 46 Washington Post US Newswire. Clinical trial finds diet and exercise dramatically delay type 2 diabetes; diabetes medication metformin also effective.  Washington Post. August 8, 2001.
  • 47 Hermann L S, Ranstam J, Vaaler S, Melander A. Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.  Diabetes Obes Metab . 1999;  1 227-232
    CrossrefPubMedSearch in Google Scholar
  • 48 Bucher H C, Griffith L E, Guyatt G H. Systematic review on risk and benefit of different cholesterol lowering interventions.  Aterioscler Thromb Vasc Biol . 1999;  19 187-195
    PubMedSearch in Google Scholar
  • 49 Muldoon M F, Manuck S B, Matthews K A. Lowering cholesterol concentration and mortality.  BMJ . 1990;  301 309-314
    PubMedSearch in Google Scholar
  • 50 Downs M R, Clearfield M , Weis S . et al . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas coronary atherosclerosis prevention study.  JAMA . 1998;  279 1615-1622
    CrossrefPubMedSearch in Google Scholar